title: Kinase inhibitors overachieve in CLL.
authors.forename: Ken
authors.initials: K
authors.lastname: Garber
mesh_terms: D000818:Animals; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000737:chemistry / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic / Q000379:methods; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000201:enzymology*; D047428:Protein Kinase Inhibitors / Q000737:chemistry / Q000627:therapeutic use*; D011687:Purines / Q000737:chemistry / Q000627:therapeutic use; D052999:Quinazolinones / Q000737:chemistry / Q000627:therapeutic use; D013449:Sulfonamides / Q000737:chemistry / Q000627:therapeutic use
chemical_list: D019086:Bridged Bicyclo Compounds, Heterocyclic; D047428:Protein Kinase Inhibitors; D011687:Purines; D052999:Quinazolinones; D013449:Sulfonamides; C579720:venetoclax; C552946:idelalisib